US Lawmakers Hit FDA Over ‘Inadequate’ Scrutiny of Indian, Chinese Sites
This article was originally published in PharmAsia News
Executive Summary
US lawmakers have voiced concern to a government watchdog body that the US Food and Drug Administration’s policing of Indian and Chinese drug factories is “inadequate” and could harm consumer safety in the US.